Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 124 results for "Byetta"

Exclusive License Agreement with AstraZeneca in Respect of Bye...

To read more Press Release articles, click here. Share this Article Google Facebook LinkedIn Tweeter Related News Recent Reports Mapping the Patient Journey: Harnessing the power of big data and analytics (Ref. FirstWord Dossier) ... FirstWord Pharma, 1 week ago

Next stop in AstraZeneca fire sale: China

Dive Brief: AstraZeneca has sold off licensing rights to its diabetes drugs Byetta and Bydureon in China, pocketing $50 million upfront from a subsidiary of the Chinese 3SBio as it continues to shed non-core assets. The deal could be worth another ...
 BioPharma Dive1 week ago AZ taps 3SBio to help drive sales of diabetes meds Byetta, Bydureon in China  FiercePharma1 week ago 3SBio Pays $100 Million To Market Two AstraZeneca PLC Diabetes Drugs In China  BioSpace1 week ago

AstraZeneca grants 3SBio Chinese rights to Byetta and Bydureon

AstraZeneca has granted Chinese biotech firm 3SBio an exclusive license to commercialize type
 Pharma Letter1 week ago 3SBIO : granted exclusive license of diabetes drugs  4 Traders1 week ago 3SBio (01530) wins AstraZeneca's exclusive license  InfocastFN.com1 week ago 3SBio (01530) granted exclusive license of diabetes drugs week ago

AstraZeneca Pharmaceuticals' Trademark Application for "BYETTA A SU LADO" Filed

By a News Reporter-Staff News Editor at Drug Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for "BYETTA A SU LADO" by Marc Stanislawczyk, representing AstraZeneca ...
 Pharmacy Choice1 month ago

'Quid pro quo' claim sets up Trump pivot...if he takes it

**Want FOX News Halftime Report in your inbox every day? Sign up here.** On the roster: Quid pro quo claim sets up Trump pivot…if he takes it - Swing states reflect Trump slide - Hillary spends big in red states, expanding her map - Rubio talks ...
 FOXNews.com2 days ago

Novel Treatments Target Type-2 Diabetes

Diabetes is a group of diseases characterized by elevated levels of blood glucose resulting from problems in how insulin is produced, how it works, or both. Type-1 diabetes (T1D)—previously known as insulin-dependent diabetes mellitus or ...
 P&T Community3 days ago Diabetes Medicine Victoza in Clinical Trial for Parkinson's Disease Treatment  Parkinson'sNewsToday.com1 month ago

Week In Review: China Resources Pharma To Price $2 Billion Hong Kong IPO This Week

Deals and Financings The historic $2 billion Hong Kong IPO for China Resources Pharma Group will start taking orders on October 13, price on October 20 and begin trading on October 28. CR Pharma, a subsidiary of state-owned China Resources ...
 Seeking Alpha4 days ago

Antidiabetics Market Dynamics, Forecast, Analysis and Supply Demand 2015-2020

Antidiabetics Market Analysis, Trends, Segment & Forecast up to 2020 This press release was orginally distributed by SBWire Deerfield Beach, FL -- (SBWIRE) -- 10/14/2016 -- Diabetes mellitus, commonly known as diabetes, is a group of metabolic ...
 Digital Journal6 days ago

AstraZeneca Plc (NYSE:AZN) Offloads Two Diabetes Drugs to Focus on Core Therapeutic Areas

AstraZeneca Plc (NYSE:AZN) has once again reiterated its intention to focus on core therapeutic areas with the signing of a new commercialization agreement with a subsidiary of 3SBio, in China. The exclusive licensing agreement is for the sale of ...
 4 Traders6 days ago AstraZeneca Plc (ADR) (AZN) Offloads Two Diabetes Drugs to Focus on Core Therapeutic Areas  Yahoo! Finance6 days ago

Prescribed Reading: AZ sell-off, Merck wins ESMO, generics dominate

Biopharma is a complex, rapidly evolving industry that is highly regulated and closely watched — and that means there is constant news. Here's a closer look at the clinical trials, M&A, cool science and regulations that are driving the industry ...
 BioPharma Dive6 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less